Eulexin®, Flutamide is indicated for use in combination with LHRH agonistic analogues for the treatment of metastatic prostatic carcinoma (stage d2). To achieve the benefit of the adjuctive therapy with eulexin, treatment must be started simultaneously using both drugs.
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.